Core Scientific (CORZ) Cost of Revenue (2021 - 2026)

Core Scientific has disclosed Cost of Revenue across 6 years of filings, most recently posting $94.2 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 27.93% year-over-year to $94.2 million; the TTM figure through Jun 2026 stood at $315.5 million (down 4.56% YoY), while the FY2025 annual figure was $281.1 million, down 27.84% from the prior year.
• Cost of Revenue came in at $94.2 million for Q2 2026 at Core Scientific, up from $85.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $189.6 million in Q3 2022 to a low of $59.0 million in Q4 2025.
• Average Cost of Revenue over 5 years is $103.4 million, with a median of $94.8 million recorded in 2024.
• Year-over-year, Cost of Revenue soared 246.61% in 2022 and sank 48.6% in 2023.
• Over 5 years, Cost of Revenue stood at $168.5 million in 2022, then tumbled by 39.09% to $102.6 million in 2023, then decreased by 12.15% to $90.2 million in 2024, then sank by 34.55% to $59.0 million in 2025, then surged by 59.57% to $94.2 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $94.2 million in Q2 2026, $85.1 million in Q1 2026, and $59.0 million in Q4 2025.